肿瘤药学2024，Vol.14Issue(6)：702-706,5.DOI:10.3969/j.issn.2095-1264.2024.06.08
肾细胞癌分子靶向治疗耐药性研究进展
Progress in molecular targeted therapy resistance of renal cell carcinoma
廉珂 1王渤文 1倪少滨1
作者信息
- 1. 哈尔滨医科大学附属第一医院 泌尿外科,黑龙江 哈尔滨,150001
- 折叠
摘要
Abstract
In recent years,molecular targeted therapy for renal cell carcinoma(RCC)has developed rapidly,resulting in a variety of targeted therapies,which greatly improve the survival rate of patients with advanced metastatic renal cancer,but due to the presence of drug resistance,patients often cannot achieve complete remission.Only by grasping the mecha-nism of drug resistance can we overcome the drug resistance of targeted therapy and improve the therapeutic effect.In this paper,the resistance mechanism of molecular targeted therapy is discussed,which provides a theoretical basis for future clinical research work.关键词
肾细胞癌/靶向治疗/耐药性/研究进展Key words
Renal cell carcinoma/Targeted therapy/Drug resistance/Research progress分类
医药卫生引用本文复制引用
廉珂,王渤文,倪少滨..肾细胞癌分子靶向治疗耐药性研究进展[J].肿瘤药学,2024,14(6):702-706,5.
